These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 36479126)

  • 1. Integrated analysis of multiple microarray studies to establish differential diagnostic models of Crohn's disease and ulcerative colitis based on a metalloproteinase-associated module.
    Deng J; Zhao N; Lv LP; Ma P; Zhang YY; Xu JB; Zhou XP; Chen ZA; Zhang YY
    Front Immunol; 2022; 13():1022850. PubMed ID: 36479126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods.
    Chen ZA; Ma HH; Wang Y; Tian H; Mi JW; Yao DM; Yang CJ
    Sci Rep; 2023 Feb; 13(1):2694. PubMed ID: 36792688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn's disease from ulcerative colitis.
    James JP; Nielsen BS; Christensen IJ; Langholz E; Malham M; Poulsen TS; Holmstrøm K; Riis LB; Høgdall E
    Sci Rep; 2023 Oct; 13(1):18421. PubMed ID: 37891214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of hub inflammatory bowel disease biomarkers and identification of immune-related functions based on basement membrane genes.
    Lin P; Hua J; Teng Z; Lin C; Liu S; He R; Chen H; Yao H; Ye J; Zhu G
    Eur J Med Res; 2023 Jul; 28(1):247. PubMed ID: 37481583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
    Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
    World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying candidate genes for discrimination of ulcerative colitis and Crohn's disease.
    Lin LJ; Zhang Y; Lin Y; Jin Y; Zheng CQ
    Mol Biol Rep; 2014 Oct; 41(10):6349-55. PubMed ID: 25182475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling.
    Sipos F; Galamb O; Wichmann B; Krenács T; Tóth K; Leiszter K; Muzes G; Zágoni T; Tulassay Z; Molnár B
    Dis Markers; 2011; 30(1):1-17. PubMed ID: 21508504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease.
    Erfan R; Shaker OG; Khalil MAF; Mahmoud FAM; Gomaa MS; Abu-El-Azayem AK; Zaki OM; Ahmed AM; Samy A; Mohammed A
    Inflamm Bowel Dis; 2024 Sep; 30(9):1500-1509. PubMed ID: 38190238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
    Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
    Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
    Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
    Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA methylation machinery and m
    Motawi TK; Shaker OG; Amr G; Senousy MA
    Clin Chim Acta; 2024 Jul; 561():119831. PubMed ID: 38925436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
    Plevy S; Silverberg MS; Lockton S; Stockfisch T; Croner L; Stachelski J; Brown M; Triggs C; Chuang E; Princen F; Singh S
    Inflamm Bowel Dis; 2013 May; 19(6):1139-48. PubMed ID: 23518807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
    Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
    World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
    Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
    Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease.
    Bjerrum JT; Nyberg C; Olsen J; Nielsen OH
    J Intern Med; 2014 May; 275(5):484-93. PubMed ID: 24206446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.